Search

Your search keyword '"Gómez-Ansón, B."' showing total 162 results

Search Constraints

Start Over You searched for: Author "Gómez-Ansón, B." Remove constraint Author: "Gómez-Ansón, B."
162 results on '"Gómez-Ansón, B."'

Search Results

52. In vivo 1H-magnetic resonance spectroscopy of the spinal cord in humans.

55. Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints.

56. Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington's Disease.

57. Recommendations for the diagnosis and radiological follow-up of pituitary neuroendocrine tumours.

58. Tipping the scales: how clinical assessment shapes the neural correlates of Parkinson's disease mild cognitive impairment.

59. Low skeletal muscle mass assessed directly from the 3rd cervical vertebra can predict pharyngocutaneous fistula risk after total laryngectomy in the male population.

60. Structure and Dynamics of Large-Scale Cognitive Networks in Huntington's Disease.

61. Grey matter microstructural alterations in schizophrenia patients with treatment-resistant auditory verbal hallucinations.

62. Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease.

63. Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia.

64. COVID-19-associated ophthalmoparesis and hypothalamic involvement.

65. The Free and Cued Selective Reminding Test in Parkinson's Disease Mild Cognitive Impairment: Discriminative Accuracy and Neural Correlates.

66. A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment.

67. Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease.

68. Emotional fMR auditory paradigm demonstrates normalization of limbic hyperactivity after cognitive behavior therapy for auditory hallucinations.

69. Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.

70. Depression and Anxiety Scores Are Associated with Amygdala Volume in Cushing's Syndrome: Preliminary Study.

71. Balo concentric sclerosis: A presentation mimicking ischaemic stroke.

72. Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

73. Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.

74. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.

75. Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion.

76. Stroke caused by a myxoma stenosing the common carotid artery.

77. Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls.

78. Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations.

79. Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome.

80. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).

81. Predicting dementia development in Parkinson's disease using Bayesian network classifiers.

82. Effects of illness duration and treatment resistance on grey matter abnormalities in major depression.

83. Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.

84. Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.

85. Altered default network resting state functional connectivity in patients with a first episode of psychosis.

86. Rapidly progressive dementia: experience in a tertiary care medical center.

87. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.

88. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.

89. Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients.

90. Medial temporal lobe correlates of memory screening measures in normal aging, MCI, and AD.

91. Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer Disease subjects.

92. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.

93. Spanish Multicenter Normative Studies (NEURONORMA Project): methods and sample characteristics.

94. Isolated frontal disequilibrium as presenting form of anti-Hu paraneoplastic encephalomyelitis.

95. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia.

96. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study.

97. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis.

98. Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study.

99. [Radiologic features of lung diseases in HIV infection in children].

100. Squamous cell carcinoma of the larynx in a 29-year-old man with AIDS.

Catalog

Books, media, physical & digital resources